
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.070 | 2.350 | 0.280 |
Shares | 97.930 | 97.930 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 15.732 | 15.891 |
Price to Book | 3.859 | 3.768 |
Price to Sales | 5.656 | 5.106 |
Price to Cash Flow | 14.169 | 14.694 |
Dividend Yield | 0.760 | 0.523 |
5 Years Earnings Growth | 4.334 | 6.307 |
Number of long holdings: 57
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Vertex | US92532F1003 | 9.59 | 374.46 | +2.16% | |
Alnylam | US02043Q1076 | 7.07 | 435.00 | -0.90% | |
Neurocrine | US64125C1099 | 5.04 | 123.98 | -0.82% | |
Guardant Health | US40131M1099 | 4.67 | 54.80 | +1.05% | |
Gilead | US3755581036 | 4.61 | 120.47 | +0.89% | |
AbbVie | US00287Y1091 | 4.37 | 198.64 | +0.30% | |
Sandoz | CH1243598427 | 3.91 | 47.19 | +0.32% | |
Amgen | US0311621009 | 3.90 | 285.09 | -1.09% | |
Royalty Pharma | GB00BMVP7Y09 | 3.49 | 36.19 | -3.70% | |
Roivant Sciences Ltd Ordinary Shares | - | 3.33 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1313519925 | 6.42B | 1.26 | -3.22 | 4.62 | ||
LU1300848345 | 6.42B | 1.40 | -2.93 | - | ||
LU1323611266 | 4.15B | 4.17 | 7.52 | - | ||
LU1520716801 | 4.15B | 2.07 | 8.35 | - | ||
UBS lux Eq SICAV USAGrwth USD Q Acc | 3.44B | 9.37 | 21.31 | 14.85 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review